424 related articles for article (PubMed ID: 11598267)
1. A phosphatase associated with metastasis of colorectal cancer.
Saha S; Bardelli A; Buckhaults P; Velculescu VE; Rago C; St Croix B; Romans KE; Choti MA; Lengauer C; Kinzler KW; Vogelstein B
Science; 2001 Nov; 294(5545):1343-6. PubMed ID: 11598267
[TBL] [Abstract][Full Text] [Related]
2. PRL-3 expression in metastatic cancers.
Bardelli A; Saha S; Sager JA; Romans KE; Xin B; Markowitz SD; Lengauer C; Velculescu VE; Kinzler KW; Vogelstein B
Clin Cancer Res; 2003 Nov; 9(15):5607-15. PubMed ID: 14654542
[TBL] [Abstract][Full Text] [Related]
3. Cancer research. New insights into metastasis.
Marx J
Science; 2001 Oct; 294(5541):281-2. PubMed ID: 11598274
[No Abstract] [Full Text] [Related]
4. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
5. PRL-3: a metastasis-associated phosphatase in search of a function.
Bessette DC; Wong PC; Pallen CJ
Cells Tissues Organs; 2007; 185(1-3):232-6. PubMed ID: 17587829
[TBL] [Abstract][Full Text] [Related]
6. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
7. Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.
Li J; Guo K; Koh VW; Tang JP; Gan BQ; Shi H; Li HX; Zeng Q
Clin Cancer Res; 2005 Mar; 11(6):2195-204. PubMed ID: 15788667
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of the human PRL-3 gene is associated with the metastasis of primary non-small cell lung cancer.
Yamashita S; Masuda Y; Matsumoto K; Okumura Y; Matsuzaki H; Kurizaki T; Haga Y; Katafuchi S; Murayama T; Ikei S; Kawahara K
Ann Thorac Cardiovasc Surg; 2007 Aug; 13(4):236-9. PubMed ID: 17717498
[TBL] [Abstract][Full Text] [Related]
9. [Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma].
Zhao GP; Zhou ZG; Lei WZ; Yu YY; Zheng XL; Gao HK
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):237-40. PubMed ID: 16167237
[TBL] [Abstract][Full Text] [Related]
10. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases.
Gotley DC; Reeder JA; Fawcett J; Walsh MD; Bates P; Simmons DL; Antalis TM
Oncogene; 1996 Aug; 13(4):787-95. PubMed ID: 8761300
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
[TBL] [Abstract][Full Text] [Related]
12. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.
Di Renzo MF; Olivero M; Giacomini A; Porte H; Chastre E; Mirossay L; Nordlinger B; Bretti S; Bottardi S; Giordano S
Clin Cancer Res; 1995 Feb; 1(2):147-54. PubMed ID: 9815967
[TBL] [Abstract][Full Text] [Related]
13. EphB2 is a prognostic factor in colorectal cancer.
Jubb AM; Zhong F; Bheddah S; Grabsch HI; Frantz GD; Mueller W; Kavi V; Quirke P; Polakis P; Koeppen H
Clin Cancer Res; 2005 Jul; 11(14):5181-7. PubMed ID: 16033834
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
[TBL] [Abstract][Full Text] [Related]
15. PRL-3 phosphatase is implicated in ovarian cancer growth.
Polato F; Codegoni A; Fruscio R; Perego P; Mangioni C; Saha S; Bardelli A; Broggini M
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6835-9. PubMed ID: 16203771
[TBL] [Abstract][Full Text] [Related]
16. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer.
Yamasaki M; Takemasa I; Komori T; Watanabe S; Sekimoto M; Doki Y; Matsubara K; Monden M
Int J Oncol; 2007 Jan; 30(1):129-38. PubMed ID: 17143521
[TBL] [Abstract][Full Text] [Related]
17. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy.
Wallin AR; Svanvik J; Adell G; Sun XF
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):452-8. PubMed ID: 16626893
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
[TBL] [Abstract][Full Text] [Related]
19. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3.
Peng L; Jin G; Wang L; Guo J; Meng L; Shou C
Biochem Biophys Res Commun; 2006 Mar; 342(1):179-83. PubMed ID: 16472776
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis.
Chen J; Röcken C; Lofton-Day C; Schulz HU; Müller O; Kutzner N; Malfertheiner P; Ebert MP
Carcinogenesis; 2005 Jan; 26(1):37-43. PubMed ID: 15375009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
